Multiple genotypes, multiple phenotypes, and partial defects

Muscle & Nerve
R A Kark, D M Becker

Abstract

In recent years, the following ideas have been expressed: (a) that all cases of a discrete, inherited neuromuscular syndrome should prove to be due to a single biochemical defect, (b) that any single biochemical defect should give rise only to one syndrome, and (c) that an enzymatic defect cannot give rise to a disease unless there is virtual absence of activity, that is, less than 5% or 10% of the normal value. We review evidence from research in neuromuscular, neurological, and other genetic diseases of humans that suggest the contrary. There are now examples of single clinical syndromes related to each of several defects, of defects of one biochemical reaction related to two or more distinct clinical syndromes, and of partial defects associated with disease in a way that suggests a causal relationship.

References

Dec 4, 1976·Lancet·G H ElderN Thomas
Nov 1, 1978·Neurology·S DiMauro, P L Hartlage
Nov 1, 1978·Annals of Neurology·W G Johnson, A B Chutorian
Mar 1, 1979·Neurology·J P Blass
Jan 1, 1978·Journal of Inherited Metabolic Disease·H Rembold
Jan 1, 1978·Journal of Inherited Metabolic Disease·S O LieJ Steen-Johnsen
Jun 21, 1979·Nature·J L GoldsteinM S Brown
Aug 9, 1979·Nature·M J Brennan, R C Cantrill
Sep 1, 1977·Medicine·D M Becker, S Kramer
Jan 1, 1978·Muscle & Nerve·S DiMauroC Payne
May 1, 1979·Medicine·J M LamonD P Tschudy
Jan 1, 1979·American Journal of Hematology·D J ViljoenR Bernstein
Feb 1, 1979·Scandinavian Journal of Clinical and Laboratory Investigation·S E Vollset, M Farstad
Dec 1, 1977·British Journal of Haematology·S KramerJ D Viljoen
May 1, 1978·Annals of Internal Medicine·M J RezaR A Kark
Feb 7, 1977·Biochemical and Biophysical Research Communications·B Grandchamp, Y Nordmann
Jun 1, 1977·British Journal of Haematology·D M BeckerS Kramer
Sep 1, 1976·Archives of Neurology·L A Chui, T L Munsat
Jul 1, 1975·Annals of Internal Medicine·G J DharC J Watson
May 1, 1973·Archives of Neurology·H J KaydenD Steinberg
Jan 5, 1971·Biochimica Et Biophysica Acta·D BeckerS Kramer
Feb 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·D S FeldmanC J Watson
Jan 1, 1973·Neurology·A G EngelE H Lambert
Jul 1, 1973·Annals of Internal Medicine·C J WatsonZ J Petryka
Jun 15, 1972·The New England Journal of Medicine·U A MeyerH S Marver
Sep 8, 1966·Biochemical and Biophysical Research Communications·A D WaxmanD P Tschudy
Jan 12, 1967·The New England Journal of Medicine·J DancisT Rokkones
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S VoraS Piomelli
Jun 1, 1965·Archives of Neurology·E H KOLODNYW D DRUCKER

❮ Previous
Next ❯

Citations

Jan 1, 1984·Journal of Inherited Metabolic Disease·J B ClarkE Byrne
Jun 1, 1986·Journal of the American College of Cardiology·J S ChildR A Kark
Nov 12, 1981·The New England Journal of Medicine·R N Rosenberg
Sep 1, 1983·Journal of Neurogenetics·H FeitR Domke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.